Patents by Inventor James LOUDIN

James LOUDIN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compositions and use of varenicline for treating dry eye
    Patent number: 11911380
    Abstract: Described herein are methods and pharmaceutical formulations for treating dry eye disease.
    Type: Grant
    Filed: March 23, 2023
    Date of Patent: February 27, 2024
    Assignee: Oyster Point Pharma, Inc.
    Inventors: Douglas Michael Ackermann, Jr., James Loudin, Kenneth J. Mandell
  • Compositions and use of varenicline for treating dry eye
    Patent number: 11903943
    Abstract: Described herein are methods and pharmaceutical formulations for treating dry eye disease.
    Type: Grant
    Filed: March 23, 2023
    Date of Patent: February 20, 2024
    Assignee: Oyster Point Pharma, Inc.
    Inventors: Douglas Michael Ackermann, Jr., James Loudin, Kenneth J. Mandell
  • Compositions and use of varenicline for treating dry eye
    Patent number: 11903941
    Abstract: Described herein are methods and pharmaceutical formulations for treating dry eye disease.
    Type: Grant
    Filed: December 6, 2021
    Date of Patent: February 20, 2024
    Assignee: Oyster Point Pharma, Inc.
    Inventors: Douglas Michael Ackermann, Jr., James Loudin, Kenneth J. Mandell
  • Compositions and use of varenicline for treating dry eye
    Patent number: 11903942
    Abstract: Described herein are methods and pharmaceutical formulations for treating dry eye disease.
    Type: Grant
    Filed: March 23, 2023
    Date of Patent: February 20, 2024
    Assignee: Oyster Point Pharma, Inc.
    Inventors: Douglas Michael Ackermann, Jr., James Loudin, Kenneth J. Mandell
  • DRY EYE TREATMENTS
    Publication number: 20230226054
    Abstract: Described herein are methods and pharmaceutical formulations for treating dry eye disease.
    Type: Application
    Filed: March 23, 2023
    Publication date: July 20, 2023
    Inventors: Douglas Michael ACKERMANN, JR., James LOUDIN, Kenneth J. MANDELL
  • DRY EYE TREATMENTS
    Publication number: 20230226053
    Abstract: Described herein are methods and pharmaceutical formulations for treating dry eye disease.
    Type: Application
    Filed: March 23, 2023
    Publication date: July 20, 2023
    Inventors: Douglas Michael ACKERMANN, JR., James LOUDIN, Kenneth J. MANDELL
  • DRY EYE TREATMENTS
    Publication number: 20230226052
    Abstract: Described herein are methods and pharmaceutical formulations for treating dry eye disease.
    Type: Application
    Filed: March 23, 2023
    Publication date: July 20, 2023
    Inventors: Douglas Michael ACKERMANN, JR., James LOUDIN, Kenneth J. MANDELL
  • DRY EYE TREATMENTS
    Publication number: 20220233528
    Abstract: Described herein are methods and pharmaceutical formulations for treating dry eye disease.
    Type: Application
    Filed: December 6, 2021
    Publication date: July 28, 2022
    Inventors: Douglas Michael ACKERMANN, JR., James LOUDIN, Kenneth J. MANDELL
  • Methods of increasing lacrimal proteins
    Patent number: 11224598
    Abstract: Described herein are methods and pharmaceutical formulations for treating dry eye disease.
    Type: Grant
    Filed: September 10, 2019
    Date of Patent: January 18, 2022
    Assignee: Oyster Point Pharma, Inc.
    Inventors: Douglas Michael Ackermann, Jr., James Loudin, Kenneth J. Mandell
  • METHODS OF TREATING OCULAR CONDITIONS
    Publication number: 20200345734
    Abstract: Described herein are methods and pharmaceutical formulations for treating ocular conditions.
    Type: Application
    Filed: April 17, 2020
    Publication date: November 5, 2020
    Inventors: Douglas Michael ACKERMANN, James LOUDIN, Kenneth J. MANDELL
  • DRY EYE TREATMENTS
    Publication number: 20200246336
    Abstract: Described herein are methods and pharmaceutical formulations for treating dry eye disease.
    Type: Application
    Filed: September 10, 2019
    Publication date: August 6, 2020
    Inventors: Douglas Michael ACKERMANN, JR., James LOUDIN, Kenneth J. MANDELL
  • Methods of treating ocular conditions
    Patent number: 10709707
    Abstract: Described herein are methods and pharmaceutical formulations for treating ocular conditions.
    Type: Grant
    Filed: April 6, 2017
    Date of Patent: July 14, 2020
    Assignee: Oyster Point Pharma, Inc.
    Inventors: Douglas Michael Ackermann, James Loudin, Kenneth J. Mandell
  • Dry eye treatments
    Patent number: 10456396
    Abstract: Described herein are methods and pharmaceutical formulations for treating dry eye disease.
    Type: Grant
    Filed: February 1, 2017
    Date of Patent: October 29, 2019
    Assignee: Oyster Point Pharma, Inc.
    Inventors: Douglas Michael Ackermann, Jr., James Loudin, Kenneth J. Mandell
  • METHODS OF TREATING OCULAR CONDITIONS
    Publication number: 20190201397
    Abstract: Described herein are methods and pharmaceutical formulations for treating ocular conditions.
    Type: Application
    Filed: April 6, 2017
    Publication date: July 4, 2019
    Applicant: Oyster Point Pharma, Inc.
    Inventors: Douglas Michael ACKERMANN, James LOUDIN, Kenneth J. MANDELL
  • Dry Eye Treatments
    Publication number: 20170239244
    Abstract: Described herein are methods and pharmaceutical formulations for treating dry eye disease.
    Type: Application
    Filed: February 1, 2017
    Publication date: August 24, 2017
    Applicant: Oyster Point Pharma, Inc.
    Inventors: Douglas Michael Ackermann, JR., James Loudin, Kenneth J. Mandell
  • Dry eye treatments
    Patent number: 9597284
    Abstract: Described herein are methods and pharmaceutical formulations for treating dry eye disease.
    Type: Grant
    Filed: October 19, 2015
    Date of Patent: March 21, 2017
    Assignee: Oyster Point Pharma, Inc.
    Inventors: Douglas Michael Ackermann, Jr., James Loudin, Kenneth J. Mandell
  • Methods of improving ocular discomfort
    Patent number: 9532944
    Abstract: Described herein are methods and pharmaceutical formulations for improving ocular discomfort.
    Type: Grant
    Filed: October 19, 2015
    Date of Patent: January 3, 2017
    Assignee: OYSTER POINT PHARMA, INC.
    Inventors: Douglas Michael Ackermann, Jr., James Loudin, Kenneth J. Mandell
  • Pharmaceutical formulations for treating ocular conditions
    Patent number: 9504645
    Abstract: Described herein are pharmaceutical formulations for treating ocular conditions.
    Type: Grant
    Filed: October 19, 2015
    Date of Patent: November 29, 2016
    Assignee: OYSTER POINT PHARMA, INC.
    Inventors: Douglas Michael Ackermann, Jr., James Loudin, Kenneth J. Mandell
  • Methods of increasing tear production
    Patent number: 9504644
    Abstract: Described herein are methods and pharmaceutical formulations for increasing tear production.
    Type: Grant
    Filed: October 19, 2015
    Date of Patent: November 29, 2016
    Assignee: OYSTER POINT PHARMA, INC.
    Inventors: Douglas Michael Ackermann, Jr., James Loudin, Kenneth J. Mandell
  • DRY EYE TREATMENTS
    Publication number: 20160106745
    Abstract: Described herein are methods and pharmaceutical formulations for treating dry eye disease.
    Type: Application
    Filed: October 19, 2015
    Publication date: April 21, 2016
    Inventors: Douglas Michael ACKERMANN, JR., James LOUDIN, Kenneth J. MANDELL